• Join
  • Login
  • Contact

Search abstracts / presentations

Formulary consideration of biosimilars

  • In: A6 - Insights into biosimilars and non-biological complex drugs on Wednesday, 3 September 2014, 9:00-12:00
  • At: Bangkok (Thailand) (2014)
  • Type: Presentation
  • By: STEVENSON, James (University of Michigan, College of Pharmacy, Ann arbor, United States of America)
  • Abstract:

    Biosimilar medicinal products have been in existence in Europe for years and will soon be available in the United States. Despite the assurance of regulatory bodies to health care professonals that all licensed biosimilar and interchangeable biological products will meet standards for safety and efficacy, concerns have been voiced in the


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses